Learn More About Scott Ballenger

SPECIAL ISSUE
July/August 2007
THE FORUM FOR THE INDUSTRY EXECUTIVE
100
of the Most
Inspiring People
P U B L I C AT I O N
www.pharmavoice.com
This is reprinted from PharmaVOICE July/August 2007
Copyright 2007 by PharmaLinx LLC
THE FORUM FOR THE INDUSTRY EXECUTIVE
Volume 7 • Number 7
PUBLISHER
EDITOR
CREATIVE DIRECTOR
Lisa Banket
Taren Grom
Marah Walsh
MANAGING EDITOR
Denise Myshko
SENIOR EDITORS
Robin Robinson
Elisabeth Pena Villarroel
FEATURES EDITOR
Kim Ribbink
CONTRIBUTING EDITORS
Cynthia Borda
Eleanor Venables, Ph.D.
DESIGN ASSOCIATE
Cathy Liszewski
NATIONAL ACCOUNT MANAGER
Cathy Tracy
CIRCULATION ASSISTANT
Robert Harrison
PharmaVOICE is published monthly except August and
December, by PharmaLinx LLC, P.O. Box 327, Titusville,
NJ 08560. Periodicals postage paid at Titusville, NJ 08560
and additional mailing offices.
Postmaster: Send address changes to PharmaVOICE,
P.O. Box 292345, Kettering, OH 45429-0345.
PharmaVOICE Coverage and Distribution:
Domestic subscriptions are available at $190 for one
year (10 issues). Foreign subscriptions: 10 issues
US$360. Contact PharmaVOICE at P.O. Box 327,
Titusville, NJ 08560. Call us at 609.730.0196 or FAX your
order to 609.730.0197.
Contributions: PharmaVOICE is not responsible for
unsolicited contributions of any type. Unless otherwise
agreed in writing, PharmaVOICE retains all rights on
material published in PharmaVOICE for a period of six
months after publication and reprint rights after that
period expires. E-mail: [email protected].
Change of address: Please allow six weeks for a change
of address. Send your new address along with your subscription label to PharmaVOICE, P.O. Box 292345, Kettering,
OH 45429-0345. Call us at 800.607.4410 or FAX your change
to 937.890.0221. E-mail: [email protected].
IMPORTANT NOTICE: The post office will not forward
copies of this magazine. PharmaVOICE is not responsible for replacing undelivered copies due to lack of or
late notification of address change.
Advertising in PharmaVOICE: To advertise in PharmaVOICE please contact our Advertising Department at
P.O. Box 327, Titusville, NJ 08560, or telephone us at
609.730.0196. E-mail: [email protected].
Letters
Send your letters to [email protected]. Please include your name, title,
company, and business phone number. Letters chosen for publication may be edited for
length and clarity. All submissions become
the property of PharmaLinx LLC.
2
July/August 2007
p h a r m a c e u t i c a l a n d l i f e-
sciences industries, it is our
p l e a s u r e t o onc e a g a i n b e
a b l e t o r e l a t e t h e p o s i t i ve
aspects of our industry.
We want to thank the thousands of
individuals who took the time to send in
their thoughtful write ups as part of the
submission process, describing how our
2007 honorees inspired, motivated, or
moved them in some way. Once again, the
PharmaVOICE 100 were selected based on
these write ups as well as the number of
nominations received and other factors, such
as community and philanthropic activities.
We thank all of you who took the time to
make the third annual PharmaVOICE 100
a success.
We are happy to showcase this distinguished group of men and women who are
having a tremendous influence on the industry and impacting corporate strategies, business development, research and development, marketing and creativity, technology,
leadership, and innovation.
We have divided the honorees into different categories that we think best capture
their skill sets and expertise. Please note
that all of this year’s honorees could easily
fit into more than one of the following sections: commanders & chiefs, the risk takers,
movers & shakers, brand champions,
researchers & scientists, patient advocates,
technologists, and mentors.
The PharmaVOICE 100 represent a
broad cross-section of industry sectors —
pharmaceutical,
biopharmaceutical,
biotechnology, contract research, clinical
trial, research and development, patient
education, patient recruitment, advertising,
technology, and many others — as well as a
variety of roles and job functions. Furthermore, their accomplishments are just as
diverse; the 100 people profiled in this issue
contribute to the growth and well-being of
not only their companies, but to their communities and peer-group associations.
These profiles are intended to give you a
snapshot of the individual, their accomplishments, a sense of their leadership style, and a
glimpse into the person behind the desk.
These individuals truly represent a global
community of thought leaders; they have
PharmaVOICE
We hope that the individuals profiled in this
special issue spark your imagination through
their inspiration,motivation,and influence on
the life-sciences industry.
roots from near and far — from the United
States to South Africa to India to Pakistan to
the United Kingdom to France and so on.
It’s also interesting to note that many of
our leaders of today had humble beginnings with first jobs that entailed everything from paper routes to washing cars to
flipping burgers to spinning records as a
disc jockey to sorting tomatoes at a farmer’s
market to busing tables to an operating
elevator on Lake Shore Drive to tearing
labels off defective cans in a pet food factory, with a #10 nail — at a penny per can.
I was particularly interested to note
what’s on their reading lists. Again, the
variety and diversity of their interests are
amazing — from the next Harry Potter
installment to books on history and business to today’s business journals and industry-specific references.
I hope you enjoy getting to know this
distinguished group as much as we did.
With a special thanks to Cathy Liszewski
for her design and to Kim Ribbink, and
on behalf of the rest of editorial team of
PharmaVOICE — Denise Myshko, Elisabeth Pena Villarroel, Robin Robinson, and
Eleanor Venables — I want to thank our
100 for making this issue possible. We
look forward to many more inspiring conversations, and we can’t wait to see who
makes next year’s list.
Taren Grom
Editor
The PharmaVOICE 100
Copyright 2007
by PharmaLinx LLC, Titusville, NJ
Printed in the U.S.A.
Volume Seven, Number Seven
W
ith so much negative press
these days surrounding the
THE MOVERS & SHAKERS
THE MOVERS & SHAKERS
These individuals are impacting change across the industry and their companies, are recognized as
experts in their fields, and are selfless in sharing their insights in an effort to raise the bar for all.
SCOTT BALLENGER
THE
GO-TO GUY
CURRENT POSITION
President, Trial Acceleration Institute Inc.
PLACE OF BIRTH
Raleigh, N.C.
EDUCATION
B.S., Pharmacy with Highest Honors and
Distinction, University of North Carolina at
Chapel Hill; Hollingsworth Scholar, full
academic scholarship
ON HIS READING LIST
Seeing What’s Next by Clayton Christensen;
The Making of a Chef by Michael Ruhlman; In
Search of Excellence by Tom Peters; China, Inc.
by Ted Friedman; Managing in Times of Great
Change by Peter Drucker; Leading the
Revolution by Gary Hamel
Years of experience and an ability to listen, gather information, and offer recommendations has made Scott Ballenger an excellent resource to
FIRST INDUSTRY JOB
Pharmaceutical sales representative, Glaxo
companies across the life-sciences
industry, especially when it comes to
PERSON WHO HAS INSPIRED HIM
patient-recruitment initiatives.
Tom Peters’ iconoclastic borderline rants “I’m not
Mr. Ballenger has been a tremendous
happy unless I’m mad”and his unyielding drive
for improvement inspired Mr. Ballenger almost
contributor to the business of accelerating
20 years ago when he received In Search of
clinical trials and providing innovative
Excellence upon graduation from pharmacy
technologies to the industry. Often the first
school; most recently, Mr. Peters’ Re-Imagine was
person mentioned when it comes to finda key driver in convincing him to found the Trial
ing someone to provide advice on enhancAcceleration Institute
ing patient recruitment for clinical trials,
Mr. Ballenger has been a driving force
behind contemporary practices for many years. He has been a founding team member of a
number of start-up companies; contributed to three venture capital rounds, two IPOs, one
turnaround, and multiple acquisitions; and has propelled two companies from early-stage
to industry leader in fewer than three years. All in all, he has helped to provide outstanding, industry-class growth.
In providing advice to the more than 60 pharmaceutical and biotech companies he has
worked with, Mr. Ballenger draws on his extensive industry experience and well-rounded
perspective of global drug development and commercialization.
He has held positions of significant responsibility across the spectrum of drug-developFIRST JOBS
Two paper routes, 10 lawns to mow, dozens of
cars to wash
ment stakeholders, including pharma, discovery,
CRO, SMO, as well as media and data-driven
patient recruitment service providers. He has
toured the gamut of the industry, working in
drug discovery, clinical development, commercial operations, and even interning in manufacturing. To round the picture of experience, Mr.
Ballenger has been a volunteer in several clinical
trials.
As founder of the Trial Acceleration Institute, he built a critical forum for defining
important strategies to accelerate clinical trials.
Mr. Ballenger invests a significant amount of
time in presenting his innovative ideas to
groups both within pharma and in the broader
healthcare community. Always able to deliver a
product on time, Mr. Ballenger demonstrates
innovation, knowledge, and commitment to
excellence in all his business activities and in the
vigor with which he approaches all challenges.
Scott Ballenger is genuinely innovative, exceptionally wellinformed and well-connected in the industry, and completely committed to excellence.
PharmaVOICE
July/August 2007
3
WHO’S ON THE LIST — 2007
The Commanders & Chiefs..............10
Mehmood Khan, 10
M.D.
Takeda Global Research and
Development Center Inc.
34 Kirk Gallion
Octagon Research
Solutions Inc.
Susan Miller Viray 38
The CementWorks
40 Jean Paty, Ph.D.
invivodata Inc.
Gene Guselli 43
InfoMedics Inc.
Al Altomari
Ahsan Awan
Christopher Begley
Bassil Dahiyat, Ph.D.
Jean-Francois Dehecq
Larry Downey
Sonja Foster
Christopher Gallen, M.D., Ph.D.
Kirk Gallion
Terrell Herring
Bruce Kehr, M.D.
Mehmood Khan, M.D.
Gregory Lucier
Geoff Mackay
Francis O’Donnell Jr., M.D.
Nigel Page
Anne Faulkner Schoemaker
Martin Soeters
Shelley Spencer
Leonard Tacconi
Nancy Mensch Turett
Josef von Rickenbach
Sandra Wrobel
The Risk Takers ..................................38
44 Jeffrey Williams
Clinipace Inc.
JeanMarie 50
Markham,
CCRA, RN
Clinlogix
58 Eve Dryer
Vox Medica
Jeff Taylor 59
Columbia MedCom Group
68 L. Stephan Vincze
TAP Pharmaceutical
Products Inc.
Scott Ballenger 72
Trial Acceleration
Institute Inc.
Frank Baldino Jr., Ph.D.
Richie Bavasso
Howard Birndorf
Daniel Donovan
Jeffrey Drezner, M.D., Ph.D.
Michael Feehan, Ph.D.
Gene Guselli
JeanMarie Markham, CCRA, RN
Steve Parker Jr.
Jean Paty, Ph.D.
Stephen Pomeranz, M.D.
James Rogers
Tarek Sherif
Dan Skovronsky, M.D., Ph.D.
Betsy Brown Stewart
Zikria Syed
Jeff Tangney
Victoria Tifft
Jeffrey Williams
Susan Miller Viray
Indexed by Section
The Movers & Shakers ..............................................continued
Lisa La Luna
Sylvia McBrinn
Timothy Poole, Pharm.D.
Beth Anne Price
Ira Spector
Robert Stirling
Jeff Taylor
L. Stephan Vincze
Rosemarie Yancosek
The Brand Champions ......................78
Rich Campbell
Dave Chapman
Ken Keller
Laurie Myers, Ph.D.
Michael Myers
Marci Piasecki
Julia Ralston
Peter Siegel
David Templeton
Natalie Yeadon
The Researchers & Scientists ......90
Matthew Coffey, Ph.D.
Barry Eisenstein, M.D.
Robert Lanza, M.D.
Christine Smith
Ana Szarfman, M.D., Ph.D.
The Patient Advocates ....................94
Nancy Dreyer, MPH, Ph.D.
Lisa Fell
Kenneth Getz
Rob Laurens
Abbey Meyers
Brenda Snow
Zane Wilson
The Technologists............................100
William “Al” Godley
Patrick Lindsay
Kelly Myers
Chan Russell
Vikas Vats
Matt Wallach
The Movers & Shakers........................58
The Mentors ......................................104
Robert Baldini
Scott Ballenger
Carrie Cox
Craig DeLarge
Barbara Deptula
Peter DiBiaso
Eve Dryer
Cameron Durrant, M.D.
Adele Gulfo
Raymond Hill
William Bailey, Pharm.D.
John Philip Bamforth, Ph.D.
T. G. Chandrashekhar, Ph.D.
Santino Costanzo
Jack Devlin
Kevin Glover
Sarah Harrison
Ken Jones
Timothy Noffke
Joseph Stauffer, D.O.
To access Podcasts featuring these thought leaders,
visit pharmavoice.com/podcasts.
4
July/August 2007
PharmaVOICE